His scientific interests lie mostly in Immunology, Molecular biology, Cell biology, Monoclonal antibody and Fas ligand. His Immunology study integrates concerns from other disciplines, such as Peripheral blood mononuclear cell, Gene signature and Lung. His Molecular biology study combines topics in areas such as Receptor, Signal transduction, MHC class II and Follicular dendritic cells.
He interconnects Endothelium, Immune system and Monocyte in the investigation of issues within Cell biology. His Monoclonal antibody study results in a more complete grasp of Antibody. His study in Antibody is interdisciplinary in nature, drawing from both Palivizumab, Virus and Virology.
His primary areas of investigation include Immunology, Antibody, Molecular biology, Monoclonal antibody and Cell biology. The Immunology study which covers Disease that intersects with Pathogenesis. His Antibody research is multidisciplinary, incorporating perspectives in Antigen and Virology.
His Molecular biology study incorporates themes from Cell, Cytotoxic T cell, CD40, T cell and Receptor. His Cell biology research incorporates themes from Fas ligand, Apoptosis, Immune system and Monocyte. Peter A. Kiener focuses mostly in the field of Cytokine, narrowing it down to topics relating to Proinflammatory cytokine and, in certain cases, Fas receptor.
Peter A. Kiener mainly focuses on Immunology, Antibody, Molecular biology, Monoclonal antibody and Virology. The various areas that Peter A. Kiener examines in his Immunology study include Dermatomyositis and Lung. His research integrates issues of Stereochemistry and Ligand in his study of Antibody.
Peter A. Kiener has researched Molecular biology in several fields, including Mole, ISG15, Interferon α and Antigen. His Monoclonal antibody research integrates issues from Nucleic acid, Expression vector and Gene isoform. His Cytokine research is multidisciplinary, relying on both Proinflammatory cytokine, Fas receptor, Monocyte-Derived Macrophages and Tumor necrosis factor alpha.
His main research concerns Immunology, Antibody-dependent cell-mediated cytotoxicity, Antibody, CD19 and Molecular biology. His research in the fields of Polymyositis, Cytokine and Eosinophil cationic protein overlaps with other disciplines such as Reslizumab. The Polymyositis study combines topics in areas such as Tumor necrosis factor alpha, Longitudinal study, Gene expression, Gene expression profiling and Signal transduction.
His Cytokine study combines topics from a wide range of disciplines, such as Pathogenesis, Inflammation, Allergic inflammation, Ovalbumin and Lung. In his study, which falls under the umbrella issue of Antibody-dependent cell-mediated cytotoxicity, Eosinophil-derived neurotoxin, Interleukin 5 and Basophil is strongly linked to Peripheral blood mononuclear cell. His research in Antibody intersects with topics in Cluster of differentiation and Antigen.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.
Jane Tian;Ana Maria Avalos;Su-Yau Mao;Bo Chen.
Nature Immunology (2007)
Properties of Human IgG1s Engineered for Enhanced Binding to the Neonatal Fc Receptor (FcRn)
William F. Dall'Acqua;Peter A. Kiener;Herren Wu.
Journal of Biological Chemistry (2006)
Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils.
W C Liles;P A Kiener;J A Ledbetter;A Aruffo.
Journal of Experimental Medicine (1996)
A Chitinase-like Protein in the Lung and Circulation of Patients with Severe Asthma
Geoffrey L Chupp;Chun Geun Lee;Nizar Jarjour;Yun Michael Shim.
The New England Journal of Medicine (2007)
MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function.
Roland Kolbeck;Alexander Kozhich;Masamichi Koike;Li Peng.
The Journal of Allergy and Clinical Immunology (2010)
Expression of functional CD40 by vascular endothelial cells.
Diane Hollenbaugh;Nicole Mischel-Petty;Caroline P. Edwards;Jan C. Simon.
Journal of Experimental Medicine (1995)
Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes
P A Kiener;P Moran-Davis;B M Rankin;A F Wahl.
Journal of Immunology (1995)
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.
Herren Wu;David S. Pfarr;Syd Johnson;Yambasu A. Brewah.
Journal of Molecular Biology (2007)
Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences
William F. Dall’ Acqua;Robert M. Woods;E. Sally Ward;Susan R. Palaszynski.
Journal of Immunology (2002)
Soluble Fas Ligand Induces Epithelial Cell Apoptosis in Humans with Acute Lung Injury (ARDS)
G Matute-Bello;W C Liles;K P Steinberg;P A Kiener.
Journal of Immunology (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
AstraZeneca (United Kingdom)
Takeda (United States)
University of Washington
AstraZeneca (United Kingdom)
Amgen (United States)
Bristol-Myers Squibb (Germany)
Nanjing University of Posts and Telecommunications
University of Washington
Duke University
University of Southern California
Zhejiang University
University of Pavia
Korea Advanced Institute of Science and Technology
Zhengzhou University
Children's Hospital of Philadelphia
University of Genoa
Nagoya University
Tokyo University of Marine Science and Technology
Nagoya University
Umeå University
GEOMAR Helmholtz Centre for Ocean Research Kiel
Colorado State University
University of Tübingen
Saarland University
Northwestern University
MIT